Professor Cheol Lee of Wonkwang University Hospital Awarded Grand Prize KIMA logo Professor Cheol Lee of Wonkwang University Hospital awarded 2015 Grand Prize at The Academic Conference of Korean Society of Anesthesiologists which was held from 5th to 7th November in BEXCO, Busan, Korea. Professor Lee got credit for the best academic accomplishment in Korea. His medical thesis 'Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia' established that high-doses of remifentanil induced hyperalgesia, which presented a decreased mechanical hyperalgesia threshold, enhanced pain intensity, a shorter time to first postoperative analgesic requirement, and greater morphine consumption, but dexmedetomidine efficiently alleviated those symptoms. Dexmedetomidine may be a novel and effective treatment option for preventing or attenuating OIH. (Quoted from http://www.ncbi.nlm.nih.gov/pubmed/23646238) Beforehand, MDlinx, which provides daily medical news for a network of 33 specialty Web sites for physicians and other healthcare professionals, selected his articles as outstanding ones third times in 2011, 2013, 2015. +82-43-713-8999, 8998, 8997 kimakorea@khidi.or.kr

Professor Cheol Lee of Wonkwang University Hospital Awarded Grand Prize

KIMA NEWS

Professor Cheol Lee of Wonkwang University Hospital Awarded Grand Prize

December 1,2015

wonkwang_anesthetics
Professor Cheol Lee of Wonkwang University Hospital awarded 2015 Grand Prize at The Academic Conference of Korean Society of Anesthesiologists which was held from 5th to 7th November in BEXCO, Busan, Korea. Professor Lee got credit for the best academic accomplishment in Korea. His medical thesis 'Antihyperalgesic effects of dexmedetomidine on high-dose remifentanil-induced hyperalgesia' established that high-doses of remifentanil induced hyperalgesia, which presented a decreased mechanical hyperalgesia threshold, enhanced pain intensity, a shorter time to first postoperative analgesic requirement, and greater morphine consumption, but dexmedetomidine efficiently alleviated those symptoms. Dexmedetomidine may be a novel and effective treatment option for preventing or attenuating OIH. (Quoted from http://www.ncbi.nlm.nih.gov/pubmed/23646238) Beforehand, MDlinx, which provides daily medical news for a network of 33 specialty Web sites for physicians and other healthcare professionals, selected his articles as outstanding ones third times in 2011, 2013, 2015.

RELATED Live

RELATED Doctor

RELATED Members

CONTACT US

Inquiry